Search Results for

*

1-10 of 10 ResultsHelp using search on aafp.org Sort by Relevance , Date , Title

Extended-Release Bupropion for Preventing Seasonal Affective Disorder in Adults - ...

Jan 1, 2017 - When started in the fall, extended-release bupropion, 300 mg once daily, is effective in preventing recurrent symptoms in high-risk adults with a history of SAD (number needed to treat [NNT] = 5), as well as those at lower risk (NNT = 8). Headaches, nausea, and insomnia may limit ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2017/0101/p10.html

Psychosocial and Psychological Interventions for Preventing Postpartum Depression - ...

Jun 1, 2014 - A range of prevention strategies can reduce the risk of postpartum depression, but more study is needed to determine which interventions are most effective.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2014/0601/p871.html

Collaborative Care for Depression and Anxiety - Cochrane for Clinicians - American ...

Apr 1, 2014 - The collaborative care model is effective for treating adults with depression and/or anxiety using a multiprofessional approach to patient care, a structured management plan, scheduled patient follow-ups, and enhanced interprofessional communication.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2014/0401/p524.html

Effectiveness of Antidepressants Compared with Placebo for Depression in Primary Care -...

Jul 1, 2010 - Tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) are more effective than placebo for the treatment of depression in primary care settings.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2010/0701/p42.html

Antidepressants in Older Persons - Cochrane for Clinicians - American Family Physician

Nov 1, 2006 - In older persons with depression, three classes of antidepressants are equally effective: selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and tricyclic-like compounds. More patients taking classic tricyclic antidepressants stopped their medications because of...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2006/1101/p1503.html

Cochrane for Clinicians - Jun 1, 2006 - American Family Physician

Jun 1, 2006 - An antidepressant such as imipramine (Tofranil) or sertraline (Zoloft), possibly with the addition of an antipsychotic, is the preferred initial pharmacologic treatment for psychotic depression.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2006/0601/p1935.html

Cochrane for Clinicians - Jun 1, 2006 - American Family Physician

Jun 1, 2006 - For adult patients who are taking a minimum maintenance dosage of inhaled corticosteroid for asthma, adding a long-acting beta2 agonist permits reduction of the dosage of inhaled corticosteroid by 253 mcg beclomethasone equivalent per day without worsening the patient's symptoms. In ...

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2006/0601/p1935a.html

Antidepressants and Smoking Cessation - Cochrane for Clinicians - American Family ...

Jan 1, 2005 - Bupropion and nortriptyline increase the likelihood of smoking cessation, but selective serotonin reuptake inhibitors (SSRIs) do not.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2005/0101/p67.html

Optimal Dosage of Tricyclic Antidepressants - Cochrane for Clinicians - American Family...

Oct 1, 2004 - Although the quality of the data limits the strength of the recommendation, current evidence shows that 75 to 100 mg per day of a tricyclic antidepressant is more effective than placebo. Higher dosages are not more effective and are associated with more dropouts because of side effects.

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2004/1001/p1270.html

Drug Treatments for Patients with Dysthymia - Cochrane for Clinicians - American Family...

Oct 1, 2004 - All antidepressants studied have similar efficacy in the treatment of patients with dysthymia. Side effect profiles vary. The largest comparisons support the use of tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs).

American Family Physician : Cochrane for Clinicians

https://www.aafp.org/afp/2004/1001/p1269.html

Page  1

25 50 100 results per page